Evidence map›Paper›PMID 34344666›Full record

ArticleBMJ global health2021

Measuring oxygen access: lessons from health facility assessments in Lagos, Nigeria.

Hamish R Graham, Omotayo E Olojede, Ayobami A Bakare, Agnese Iuliano, Oyaniyi Olatunde, Adamu Isah, Adams Osebi, Tahlil Ahmed, Obioma C Uchendu, Rochelle Burgess and 5 more

Open access · goldAbstract read
In one paragraph

Article in BMJ global health, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 3 pooled it
4.5field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 3 syntheses or guidelines pooled it, 46 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 7 institutions in 5 countries.

Hamish R GrahamCentre for International Child Health, MCRI, University of Melbourne, Royal Children's Hospital, Parkville, Victoria, Australia hamish.graham@rch.org.au.ORCID 0000-0003-2461-0463
Omotayo E OlojedeDepartment of Paediatrics, University College Hospital Ibadan, Ibadan, Oyo, Nigeria.
Ayobami A BakareDepartment of Community Medicine, University College Hospital Ibadan, Ibadan, Oyo, Nigeria.
Agnese IulianoInstitute for Global Health, University College London, London, UK.
Oyaniyi OlatundeDepartment of Paediatrics, University College Hospital Ibadan, Ibadan, Oyo, Nigeria.
Adamu IsahSave the Children Nigeria, Abuja, FCT, Nigeria.
Adams OsebiSave the Children Nigeria, Abuja, FCT, Nigeria.
Tahlil AhmedSave the Children Fund, London, UK.
Obioma C UchenduDepartment of Community Medicine, University College Hospital Ibadan, Ibadan, Oyo, Nigeria.
Rochelle BurgessInstitute for Global Health, University College London, London, UK.ORCID 0000-0001-9749-7065
Eric McCollumGlobal Program in Respiratory Sciences, Eudowood Division of Pediatric Respiratory Sciences, Department of Pediatrics, Johns Hopkins School of Medicine, Baltimore, Maryland, USA.
Tim ColbournInstitute for Global Health, University College London, London, UK.ORCID 0000-0002-6917-6552
Carina KingInstitute for Global Health, University College London, London, UK.ORCID 0000-0002-6885-6716
Adegoke G FaladeDepartment of Paediatrics, University College Hospital Ibadan, Ibadan, Oyo, Nigeria.
INSPIRING Project Consortium
University College Hospital, Ibadan · NGUniversity College London · GBUniversity of Ibadan · NGJohns Hopkins University · USKarolinska Institutet · SERoyal Children's Hospital · AUSave the Children · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The COVID-19 pandemic has highlighted global oxygen system deficiencies and revealed gaps in how we understand and measure 'oxygen access'. We present a case study on oxygen access from 58 health facilities in Lagos state, Nigeria. We found large differences in oxygen access between facilities (primary vs secondary, government vs private) and describe three key domains to consider when measuring oxygen access: availability, cost, use. Of 58 facilities surveyed, 8 (14%) of facilities had a functional pulse oximeter. Oximeters (N=27) were typically located in outpatient clinics (12/27, 44%), paediatric ward (6/27, 22%) or operating theatre (4/27, 15%). 34/58 (59%) facilities had a functional source of oxygen available on the day of inspection, of which 31 (91%) facilities had it available in a single ward area, typically the operating theatre or maternity ward. Oxygen services were free to patients at primary health centres, when available, but expensive in hospitals and private facilities, with the median cost for 2 days oxygen 13 000 (US$36) and 27 500 (US$77) Naira, respectively. We obtained limited data on the cost of oxygen services to facilities. Pulse oximetry use was low in secondary care facilities (32%, 21/65 patients had SpO

Indexed as

COVID-19OxygenChildFemaleHealth FacilitiesHumansNigeriaPandemicsPregnancySARS-CoV-2OxygenCOVID-19cross-sectional surveyhealth services researchpneumoniatreatment

Identifiers

PMID34344666
PMCPMC8336153
OpenAlexW3190018364

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.